A federal lawsuit filed over sexual assault allegations tied to Rabbi Elimelech Meisels of an ultra-Orthodox community in Chicago, follows similar allegations brought before rabbinical courts in both Chicago and Israel, so called “beis din” courts.
The federal allegations involve that Meisels, who runs Israel-based seminaries for girls, is a sexual predator, according to The Chicago Tribune. The federal lawsuit was filed by the parents of female students who seek tuition reimbursement given allegations against Meisels that include that, for 10 years, the rabbi recruited young women from cities such as Chicago to attend his Israel-based seminaries “under the guise of educational and spiritual development.” The lawsuit also accuses the rabbi of “developing mentor-mentee relationships with girls,” and bringing them on late-night coffee meetings, then sexually assaulting the young women. Meisels does not face any criminal charges, The Chicago Tribune noted. Continue reading
The September 11 Victim Compensation Fund has an important filing deadline on October 12, 2014 for those who took part in World Trade Center rescue and recovery efforts in 2001-2002 and now suffer cancers and other illnesses caused by toxic exposure.
Those who were diagnosed on or before October 12, 2012 with one of the cancers recognized by the VCF by that date must register with the VCF by October 12, 2014, according to The PBA Beat, the New York Patrolmen’s Benevolent Association newsletter. Participants in the recovery efforts who were diagnosed on or before October 21, 2013 with prostate cancer must register by October 21, 2015. Those diagnosed on or before February 18, 2014 with a “rare cancer” (as defined by the WTC Health Program) must register by February 18, 2016. Anyone diagnosed with one of the recognized cancers after the cut-off dates above may register up to two years after the date they became ill, but no later than October 3, 2016. Continue reading
Last Thursday, a federal appeals court was asked to reinstate a lawsuit filed on behalf of 34 men who allege that they were sexually abused by rabbis at Yeshiva University High School for Boys; according to their lawsuit, the school covered up the abuse for decades.
The case was previously dismissed by federal judge John G. Koeltl, who ruled that the abuse had taken place too long ago for the lawsuit to proceed. Attorneys for the plaintiffs argued that the judge misinterpreted the statute of limitations. It was not known that the school helped hide the abuse until December 2012, when The Daily Forward published an article, the plaintiffs’ attorney said. Continue reading
An $18 million settlement is being finalized over Flushmate exploding toilets, manufactured by Sloan Valve Company. The initial lawsuit, originally filed in 2012, alleged that the Series 503 Flushmate III Pressure-Assist Flushing System manufactured by Sloan can unexpectedly explode, causing injury and property damage. Continue reading
Dr. Mehmet Oz is warning against placing your cell phone in your bra, a habit that many women do out of convenience. “When it comes to cell phones, the bra has become the new purse,” Dr. Oz said on an episode of the Dr. Oz show that aired Aug. 26th. Continue reading
The US Supreme Court’s rejection of an appeal from drug maker Pfizer, letting stand a First Circuit ruling that the drug company improperly marketed the epilepsy drug Neurontin to Kaiser Foundation Health Plan, could unleash a flood of cases
Pfizer must pay Kaiser $142 million in damages for violating the Racketeer Influenced and Corrupt Organizations (RICO) Act and an additional $65.4 million for violating the California Unfair Competition Law (UCL). Continue reading
Teva Pharmaceutical Industries just issued a recall of one lot of its generic Parkinson’s disease combination medication, carbidopa/levodopa, over it potentially containing too much of an active pharmaceutical ingredient.
Teva Pharmaceutical Industries indicated that the recall, which has been deemed a Class II, involved 3,881 bottles of carbidopa/levodopa 25 mg/100 mg, according to FiercePharmaManufacturing. Teva also indicated that stability testing revealed that the recalled carbidopa/levodopa may be what the drug maker described as “super potent.” The voluntary recall is for the entire United States. Continue reading
Researchers at the University of Buffalo will be studying how chemicals in the environment affect the risk of diabetes and metabolic conditions. According to an article posted on the university’s website, the National Institute of Environmental Health Sciences has awarded a two-year $436,751 grant to Margarita L. Dubocovich, PhD and Rajendram V. Rajnarayanan, PhD to study this issue. Continue reading
A federal court order demands that BioAnue Laboratories of Rochelle, Georgia stops illegally marketing its products as treatments for disease, the U.S. Food and Drug Administration (FDA) announced on its website. The court order, which was signed on July 23, 2014 in the United States District Court for the Middle District of Georgia, says that BioAnue’s products were sold as supplements but were illegally marketed as treatments for conditions such as cancer, HIV/AIDS, heart disease, chronic obstructive pulmonary disease and diabetes. The FDA did not approve these products for those uses.
In February 2012, the FDA issued a warning lette Continue reading
For next month’s launch of the Open Payment database showing payments to physicians from pharmaceutical companies and medical device makers, about one-third of the records will be withheld because of data inconsistencies.
The release of payment information – intended to promote greater transparency about possible conflicts of interest in medicine – is mandated under the Physician Payment Sunshine Act, a provision of the 2010 Affordable Care Act, according to the non-profit investigative journalism group ProPublica. Continue reading